AURA Aura Biosciences, Inc.

Nasdaq aurabiosciences.com


$ 5.85 $ 0.18 (3.17 %)    

Friday, 24-Oct-2025 15:59:54 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 5.86
$ 5.74
$ 5.50 x 100
$ 6.84 x 10
$ 5.62 - $ 5.94
$ 4.35 - $ 11.35
336,757
na
364.02M
$ 1.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-24-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-27-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-15-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-23-2022 12-31-2021 10-K
16 11-24-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-aura-biosciences-maintains-22-price-target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Aura Biosciences (NASDAQ:AURA) with a Buy and maintains $22 p...

 hc-wainwright--co-assumes-aura-biosciences-at-buy-announces-price-target-of-22

HC Wainwright & Co. analyst Andres Maldonado assumes Aura Biosciences (NASDAQ:AURA) with a Buy rating and announces Pric...

 jmp-securities-reiterates-market-outperform-on-aura-biosciences-maintains-19-price-target

JMP Securities analyst Jonathan Wolleben reiterates Aura Biosciences (NASDAQ:AURA) with a Market Outperform and maintains $1...

 us-stocks-likely-to-open-mixed-expect-volatility-buckle-up-says-expert

U.S. stock futures were swinging between gains and losses on Thursday after snapping a three-day winning streak on Wednesday. F...

 citizens-capital-markets-maintains-market-outperform-on-aura-biosciences-lowers-price-target-to-19

Citizens Capital Markets analyst Jonathan Wolleben maintains Aura Biosciences (NASDAQ:AURA) with a Market Outperform and low...

 hc-wainwright--co-maintains-buy-on-aura-biosciences-raises-price-target-to-25

HC Wainwright & Co. analyst Edward White maintains Aura Biosciences (NASDAQ:AURA) with a Buy and raises the price target...

 hc-wainwright--co-reiterates-buy-on-aura-biosciences-maintains-22-price-target

HC Wainwright & Co. analyst Edward White reiterates Aura Biosciences (NASDAQ:AURA) with a Buy and maintains $22 price ta...

 aura-biosciences-announced-data-from-a-completed-phase-1-window-of-opportunity-trial-of-bel-sar-au-011-in-patients-with-non-muscle-invasive-bladder-cancer

Clinical Complete Responses Observed with Single Low-Dose of Bel-sar in Patients with Intermediate and High-Risk NMIBC with Rob...

 aura-biosciences-to-present-new-phase-1-data-on-bel-sar-for-non-muscle-invasive-bladder-cancer-in-late-breaking-session-at-40th-eau-congress

Aura will Participate in the Research Forum at the 40th Annual European Association of Urology CongressAura will Host a Virtual...

 hc-wainwright--co-reiterates-buy-on-aura-biosciences-maintains-22-price-target

HC Wainwright & Co. analyst Edward White reiterates Aura Biosciences (NASDAQ:AURA) with a Buy and maintains $22 price ta...

 aura-biosciences-q3-eps-042-beats-045-estimate

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION